We attended the 5th annual Leerink Partners Global Healthcare Conference 2016 from February 10 to 11 in New York.
Next to getting updates on many companies we tried to shed lights on the recent hefty correction of Biotech shares. Overall we left the conference with the view that the pull-back will offer great investment opportunities, however that it probably will take some time for unfolding. Timing will be key.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.